956 related articles for article (PubMed ID: 1002814)
1. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
3. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of testosterone metabolism in the human prostate.
Tan SY; Antonipillai I; Murphy BE
J Clin Endocrinol Metab; 1974 Nov; 39(5):936-41. PubMed ID: 4138158
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
Frick J; Bartsch G; Jakse G
Urol Res; 1977; 5(2):55-9. PubMed ID: 69351
[TBL] [Abstract][Full Text] [Related]
7. Direct effects of medroxyprogesterone acetate (MPA) and megestrol acetate (MGA) on rat testicular steroidogenesis.
Barbieri RL; Ryan KJ
Acta Endocrinol (Copenh); 1980 Jul; 94(3):419-25. PubMed ID: 6968496
[TBL] [Abstract][Full Text] [Related]
8. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
Soufir JC; Jouannet P; Marson J; Soumah A
Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
[TBL] [Abstract][Full Text] [Related]
9. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
Bain J; Rachlis V; Robert E; Khait Z
Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
[TBL] [Abstract][Full Text] [Related]
10. Treatment of breast cancer with medroxyprogesterone acetate.
Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
[TBL] [Abstract][Full Text] [Related]
11. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
12. Sebum production and plasma testosterone levels in man after high-dose medroxyprogesterone acetate treatment and androgen administration.
Novak E; Hendrix JW; Chen TT; Seckman CE; Royer GL; Pochi PE
Acta Endocrinol (Copenh); 1980 Oct; 95(2):265-70. PubMed ID: 6449127
[TBL] [Abstract][Full Text] [Related]
13. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
14. Metabolic clearance rate and blood production rate of testosterone and dihydrotestosterone in normal subjects, during pregnancy, and in hyperthyroidism.
Saez JM; Forest MG; Morera AM; Bertrand J
J Clin Invest; 1972 May; 51(5):1226-34. PubMed ID: 5020435
[TBL] [Abstract][Full Text] [Related]
15. Influence of medroxypregesteroneacetate on testosterone metabolism by cultured human fibroblasts: a model for drug-steroid interaction.
Saenger P; Shanies DD; New MI
J Clin Endocrinol Metab; 1973 Nov; 37(5):760-4. PubMed ID: 4749450
[TBL] [Abstract][Full Text] [Related]
16. The in-vitro and in-vito effects of diethylstilbestrol on testicular synthesis of testosterone.
Sholiton LJ; Srivastava L; Taylor BB
Steroids; 1975 Dec; 26(6):797-806. PubMed ID: 1216262
[TBL] [Abstract][Full Text] [Related]
17. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.
Geier R; Adler S; Rashid G; Klein A
Prostate; 2010 Sep; 70(12):1307-12. PubMed ID: 20623632
[TBL] [Abstract][Full Text] [Related]
18. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
[TBL] [Abstract][Full Text] [Related]
19. Effects of steroids on oxytocin secretion by the human prostate in vitro.
Assinder SJ; Nicholson HD
Int J Androl; 2004 Feb; 27(1):12-8. PubMed ID: 14718041
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Jeppsson S; Gershagen S; Johansson ED; Rannevik G
Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
